The market for adult and paediatric hemoconcentrators is projected to experience a CAGR of 3% during the forecast period and will be worth US$ 14.1 Million by 2027.  As perfusionists and surgeons increasingly rely on hemoconcentrators to maintain greater hematocrit levels during cardiopulmonary surgery, sales of adult and paediatric hemoconcentrators are anticipated to increase. In...